← Leaderboards
Hikmat Al-Ahmadie
Sloan-Kettering Inst Can Research
$4,559,862
Attributed
$4,559,862
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $917.7K · FY2018–24$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$4,559,862 · 3
By mechanism
R01$2,037,741 · 1
P01$1,381,076 · 1
P50$1,141,045 · 1
Top collaborators
No co-investigators on record.
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- David B. Solit$21,393,031
- Michael Stephen Glickman$43,477,930
- Luc Gordon Trang Morris$1,605,886
- Yu Chen$11,691,795
- Timothy An-Thy Chan$21,076,830
Others in their field
Other Emerging Leaders on “Sampling”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$181,167,581
- Beth Baseler · Leidos Biomedical Research, Inc.$105,136,677
- Scott Topper · Broad Institute, Inc.$77,958,806
- Paul F Gallagher · Woods Hole Oceanographic Institution$63,916,876
- Leonard Freedman · Leidos Biomedical Research, Inc.$60,323,945
- Dale Sandler · Social And Scientific Systems, Inc.$59,740,435
Research focus
SamplingMutationMorphologyGenomicsEvaluationResponseTumorTissuesMalignant Neoplasm Of Urinary BladderGeneticMalignant NeoplasmsBaseIn Situ HybridizationImmunohistochemistryLaboratoriesHuman TissueBiometryAntibodiesImmune Checkpoint BlockadeClinical ResearchBiological MarkersHeterogeneityBioinformaticsMicrodissection
Grant awards (16)
Biospecimen Repository Core$128,633
P50 · FY2024 · CA · contact PI
Defining the impact of intra-tumoral morphologic, immune and mutational heterogeneity in urothelial carcinoma$402,618
R01 · FY2023 · CA · contact PI
Defining the impact of intra-tumoral morphologic, immune and mutational heterogeneity in urothelial carcinoma$402,618
R01 · FY2022 · CA · contact PI
Core A: Molecular Pathology Core$310,130
P01 · FY2022 · CA · contact PI
Biospecimen Repository Core$199,602
P50 · FY2022 · CA · contact PI
Defining the impact of intra-tumoral morphologic, immune and mutational heterogeneity in urothelial carcinoma$410,835
R01 · FY2021 · CA · contact PI
Core A: Molecular Pathology Core$249,394
P01 · FY2021 · CA · contact PI
Biospecimen Repository Core$196,736
P50 · FY2021 · CA · contact PI
Defining the impact of intra-tumoral morphologic, immune and mutational heterogeneity in urothelial carcinoma$410,835
R01 · FY2020 · CA · contact PI
Core A: Molecular Pathology Core$249,393
P01 · FY2020 · CA · contact PI
Biospecimen Repository Core$201,847
P50 · FY2020 · CA · contact PI
Defining the impact of intra-tumoral morphologic, immune and mutational heterogeneity in urothelial carcinoma$410,835
R01 · FY2019 · CA · contact PI
Core A: Molecular Pathology Core$307,265
P01 · FY2019 · CA · contact PI
Biospecimen Repository Core$199,602
P50 · FY2019 · CA · contact PI
Core A: Molecular Pathology Core$264,894
P01 · FY2018 · CA · contact PI
Biospecimen Repository Core$214,625
P50 · FY2018 · CA · contact PI